N-(2,3-Dichlorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl]acetamide

Catalog No.: 
ACTZCI854
CAS No.: 
303091-19-2
Molecular Formula: 
C18H18Cl2FN3O
Molecular Weight: 
382.27
N-(2,3-Dichlorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl]acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$107.00InquiryInquiry
1g90%$324.00InquiryInquiry
5g90%$1588.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,3-Dichlorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl]acetamide
IUPAC NameN-(2,3-dichlorophenyl)-2-(4-(4-fluorophenyl)piperazin-1-yl)acetamide
MDL No.MFCD02675215
Molecular FormulaC18H18Cl2FN3O
Molecular Weight382.27
SMILESO=C(NC1=CC=CC(Cl)=C1Cl)CN2CCN(C3=CC=C(F)C=C3)CC2
InChI KeyMWBWUUGFDQJHPI-UHFFFAOYSA-N
SynonymN-(2,3-dichlorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl]acetamide;N-(2,3-DICHLOROPHENYL)-2-[4-(4-FLUOROPHENYL)PIPERAZINO]ACETAMIDE;1-Piperazineacetamide, N-(2,3-dichlorophenyl)-4-(4-fluorophenyl)-
CAS No.303091-19-2

Synthetic Route by SureRoute

1. ACTZCI854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTZCI854 route product structure diagram
    ACTZCI854303091-19-2
Inquiry

2. ACTZCI854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTZCI854 route product structure diagram
    ACTZCI854303091-19-2
Inquiry

3. ACTZCI854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTZCI854 route product structure diagram
    ACTZCI854303091-19-2
Inquiry

Comments (0)